Stem cell therapy market poised for $11.65b growth by 2027

The cancer segment is expected to witness notable market share growth within the forecast period.

The global stem cell therapy market is expected to grow by $11.65b until 2027 at a compound annual growth rate (CAGR) of around 15.93%.

A report by Technavio revealed that the market was driven by key factors such as increasing efforts in research and development, technological advancements, and a rising demand for personalised medicine. 

Moreover, the market is influenced by regulatory frameworks, ethical considerations, and the potential for significant cost savings in comparison to traditional treatments.

ALSO READ: Global epigenetics market to grow by $1.47b until 2028

By application, the cancer segment is expected to witness notable market share growth during the forecast period.

The segment’s growth is driven by the increased use of cell therapy for cancerous conditions. 

“Stem cell therapy for cancer treats blood-related diseases like non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma, and leukaemia,” The report said.